Literature DB >> 6767407

Epithelioid granuloma formation by a synthetic bacterial cell wall component, muramyl dipeptide (MDP).

A Tanaka, K Emori.   

Abstract

A synthetic muramyl dipeptide (MDP, N-acetylmuramyl-L-alanyl-D-isoglutamine) is a minimal essential structure that is contained generally in bacterial cell walls and is responsible for their many biologic activities such as adjuvant activity, pyrogenicity, and a capacity to confer resistance against bacterial and viral infections. We found that this MDP evoked dose-dependently massive organized epithelioid granulomas in guinea pigs, when injected in the form of Freund-type water-in-oil emulsion. Granuloma formation reached a peak at 3 weeks. A minimal effective dose of MDP was 0.1 microgram. Essentially, no difference was observed qualitatively among granulomas evoked by MDP, MDP plus antigen, and killed tubercle bacilli incorporated in the emulsion. Quantitatively, however, MDP was stronger in its granulomagenic capacity than tubercle bacilli. Antigenicity of MDP was not detectable. These findings support our proposal that MDP may be a chemical structure in tubercle bacilli essential for epithelioid granuloma formation and that the MDP-induced epithelioid granuloma may be of a nonallergic nature.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767407      PMCID: PMC1903508     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  [Histological reactions induced in the guinea pig by injection of lipopolysaccharides extracted from Koch's bacilli].

Authors:  A DELAUNAY; J ASSELINEAU; E LEDERER
Journal:  C R Seances Soc Biol Fil       Date:  1951-05

2.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

3.  Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity.

Authors:  A Tanaka; S Nagao; R Saito; S Kotani; S Kusumoto; T Shiba
Journal:  Biochem Biophys Res Commun       Date:  1977-07-25       Impact factor: 3.575

4.  Inhibition of macrophage migration by muramyl peptides.

Authors:  S Nagao; A Tanaka; Y Yamamoto; T Koga; K Onoue; T Shiba; K Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  [Enhancement of the immune response to influenza vaccine by a synthetic glycopeptide adjuvant (N-acetyl muramy1-L-analyl-D-isoglutamine)].

Authors:  F Audibert; L Chedid; C Hannoun
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1977-09-12

7.  The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues.

Authors:  C A Dinarello; R J Elin; L Chedid; S M Wolff
Journal:  J Infect Dis       Date:  1978-12       Impact factor: 5.226

8.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG).

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1974-07       Impact factor: 4.307

10.  Studies on antibody production. IV. The role of a wax fraction of Mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin.

Authors:  R G WHITE; A H COONS; J M CONNOLLY
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

View more
  15 in total

1.  Extraintestinal manifestations of granulomatous enterocolitis induced in rabbits by long-term submucosal administration of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

2.  Histochemical demonstration of mycobacterial antigen, specific antibody and complement in the lesions of tuberculosis.

Authors:  M J Ridley; D S Ridley
Journal:  Histochem J       Date:  1986-10

3.  Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.

Authors:  K Kaneda; Y Sumi; F Kurano; Y Kato; I Yano
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

4.  Epithelioid granuloma induced by muramyl dipeptide in immunologically deficient rats.

Authors:  S Nagao; F Ota; K Emori; K Inoue; A Tanaka
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

5.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  Rabbit granulomatous enterocolitis induced by injection of muramyl dipeptide emulsified with Freund's incomplete adjuvant.

Authors:  K Kuroe; Y Haga; O Funakoshi; I Mizuki; K Kanazawa; Y Yoshida
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

7.  Epithelioid granuloma formation requiring no T-cell function.

Authors:  A Tanaka; K Emori; S Nagao; K Kushima; O Kohashi; M Saitoh; T Kataoka
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

8.  Polymorphonuclear neutrophil chemotaxis modulated by Bacteroides fragilis peptidoglycan.

Authors:  J F Sperry; J M Burns
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

9.  Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog.

Authors:  H F Acevedo; R B Raikow; H O Acevedo; T F Delgado; M Pardo
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

10.  Granuloma formation and killing functions of granuloma in congenitally athymic nude mice infected with Blastomyces dermatitidis and Paracoccidioides brasiliensis.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1983-06-20       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.